Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Other financing activities (2018 - 2024)

Health Catalyst posted quarterly Other financing activities of -$848000.0 for Q4 2024, down 517.73% on a QoQ basis from $203000.0 in Q4 2019.

Health Catalyst (HCAT) has 3 years of Other financing activities data on file, last reported at -$848000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Other financing activities changed N/A year-over-year to -$848000.0; the trailing twelve-month figure through Dec 2025 stood at -$848000.0 (changed 0.0% YoY), and the FY2024 full-year result was $2.2 million, changed N/A from the prior year.
  • Other financing activities for Q4 2024 stood at -$848000.0, down from $203000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at -$848000.0 in Q4 2024 and bottomed at -$848000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Health Catalyst 98.36 Mn -10.46 Mn 35.46 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -848,000.00
Dec 31, 2024 -848,000.00
Dec 31, 2019 203,000.00
Dec 31, 2019 203,000.00
Sep 30, 2019 2.38 Mn
Sep 30, 2019 2.38 Mn
Jun 30, 2019 1.85 Mn
Jun 30, 2019 1.85 Mn
Mar 31, 2019 182,000.00
Mar 31, 2019 182,000.00
Jun 30, 2018 10,000.00
Jun 30, 2018 10,000.00